Related references
Note: Only part of the references are listed.Cumulative Antibiotic Exposures Over Time and the Risk of Clostridium difficile Infection
Vanessa Stevens et al.
CLINICAL INFECTIOUS DISEASES (2011)
Iatrogenic Gastric Acid Suppression and the Risk of Nosocomial Clostridium difficile Infection
Michael D. Howell et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection
Amy Linsky et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Drug-Drug Interaction Profiles of Proton Pump Inhibitors
Ryuichi Ogawa et al.
CLINICAL PHARMACOKINETICS (2010)
Inappropriate utilization of intravenous proton pump inhibitors in hospital practice-a prospective study of the extent of the problem and predictive factors
D. G. N. Craig et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2010)
Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea
Ji Won Kim et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting
B. R. Dalton et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Examination of Potential Mechanisms To Explain the Association between Proton Pump Inhibitors and Clostridium difficile Infection
Michelle M. Nerandzic et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Clostridium difficile infection: new developments in epidemiology and pathogenesis
Maja Rupnik et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Clostridium difficile-associated disease in a setting of endemicity:: Identification of novel risk factors
Erik R. Dubberke et al.
CLINICAL INFECTIOUS DISEASES (2007)
Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity:: a potential mechanism to explain the association between proton pump inhibitors and C-difficile-associated diarrhea?
Robin L. P. Jump et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Evaluation of Clostridium difficile -: Associated disease pressure as a risk factor for C difficile -: Associated disease
Erik R. Dubberke et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Effect of Helicobacter pylori infection and acid blockade by lansoprazole on clarithromycin bioavailability
R. A. M. Ortiz et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2007)
Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections
Jessina C. McGregor et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2006)
Proton pump inhibitors and hospitalization for Clostridium difficile-ssociated disease:: A population-based study
Donna O. Lowe et al.
CLINICAL INFECTIOUS DISEASES (2006)
In vitro killing of nosocomial pathogens by acid and acidified nitrite
Agam Rao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy
Sandra Dial et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2006)
Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease
S Dial et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
An epidemic, toxin gene-variant strain of Clostridium difficile
LC McDonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Clinical manifestations, treatment and control of infections caused by Clostridium difficile
E Bouza et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors:: cohort and case-control studies
S Dial et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2004)
Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea
R Cunningham et al.
JOURNAL OF HOSPITAL INFECTION (2003)
Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori
L Gatta et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity
K Zedtwitz-Liebenstein et al.
CRITICAL CARE MEDICINE (2002)
Transfer of metronidazole to gastric juice:: Impact of Helicobacter pylori infection and omeprazole
SA Calafatti et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2000)
Share Paper
